Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study

Overview

Full ambulatory polysomnography at home performed two nights in 30 healthy children and one night in 30 children with mono-symptomatic nocturnal enuresis (15 with polyuria and 15 without polyuria). The children will be aged 7-14 years of age. The sleep will be evaluated on sleep quality, number of periodic limb movements per hour, blood pressure and pulse, beat to beat variation by electrocardiography during sleep, respiration during sleep, nocturnal urine production, and enuresis episodes.

Full Title of Study: “Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study at Home – Differences Between Monosymptomatic Nocturnal Enuresis Patients and Healthy Controls”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2020

Detailed Description

Purpose and perspectives: The purpose of the study is to investigate the quality of sleep, the sleep architecture and the intra-individual variation from night to night in healthy children and children with mono-symptomatic nocturnal enuresis (MNE) using full polysomnography at home. Hypotheses: – There is large intra-individual night to night variation in sleep quality and architecture. – Children with MNE have different sleep architecture than healthy children when looking at sleep quality and arousals. – Periodic limp movements at sleep is more frequent in children with MNE than in healthy children. Design: The study is a case-control study. Materials and methods: The study will recruit 30 healthy children and 30 children with MNE (15 with polyuria and 15 without polyuria) recruited from the Childrens Incontinence Center at the Department of Pediatrics and Adolescent Medicine at Aarhus University Hospital. Children of both sexes aged between 7 and 14 years of age will be enrolled. Children and their parents will be informed about the study both verbally and in written. Written informed consent from both parents must be obtained before the children can be enrolled in the study. The healthy children will go through two nights of full polysomnography to be able to view intra-individual changes. The children with MNE will only have to do one night of polysomnography. Primary parameters: – Sleep quality – Number of periodic limb movements per hour – Blood pressure and pulse – Beat to beat variation by electrocardiography during sleep – Respiration during sleep – Nocturnal urine production – Enuresis episodes

Interventions

  • Device: Polysomnography (Full sleep registration)
    • For the healthy children two nights of polysomnography. For the children with nocturnal enuresis one night of polysomnography.

Arms, Groups and Cohorts

  • Healthy children
    • Healthy children 7-14 years of age.
  • Nocturnal enuresis with polyuria
    • Children with nocturnal enuresis and polyuria aged 7-14 years.
  • Nocturnal enuresis without polyuria
    • Children without nocturnal enuresis and polyuria aged 7-14 years.

Clinical Trial Outcome Measures

Primary Measures

  • Sleep efficiency
    • Time Frame: One night of polysomnography.
    • Sleep efficiency will be calculated as the ratio of the total time spent asleep to the total time spent in bed

Secondary Measures

  • Periodic limb movements during sleep
    • Time Frame: One night of polysomnography.
    • Number of periodic limb movements per hour at sleep compared between the three groups.
  • Nocturnal urine production
    • Time Frame: One night of polysomnography.
    • We will compare the nocturnal urine production in millilitres in the three groups.
  • Enuresis episodes
    • Time Frame: One night of polysomnography
    • We are going to look at the time of the enuresis episode and compare it to the polysomnographic findings at that time.
  • Respiratory events during sleep
    • Time Frame: One night of polysomnography
    • Respiration during sleep comparison between the three groups. This includes saturation, nasal air flow and movement of the stomach and chest. Together showing the number of respiratory events (apneas/hour).
  • Incidence of sleep disturbances
    • Time Frame: One night of polysomnography
    • Percentage of children with clinical sleep disturbances between patients and controls
  • Intra-individual differences in sleep efficiency from night to night in healthy controls.
    • Time Frame: Two nights of polysomnography. Each evaluated after completing the two nights.
    • Sleep efficiency (in percent) will be compared between the two nights of polysomnography in the healthy controls.
  • Intra-individual differences in periodic limb movements during sleep from night to night in healthy controls.
    • Time Frame: Two nights of polysomnography. Each evaluated after completing the two nights.
    • Periodic limb movements during sleep will be compared between the two nights of polysomnography in the healthy controls.
  • Intra-individual differences in nocturnal urine production from night to night in healthy controls.
    • Time Frame: Two nights of polysomnography. Each evaluated after completing the two nights.
    • Nocturnal urine production will be compared between the two study nights in the healthy controls.
  • Intra-individual differences in respiratory events from night to night in healthy controls.
    • Time Frame: Two nights of polysomnography. Each evaluated after completing the two nights.
    • The number and kinds of respiratory events will be compared between the two study nights in the healthy controls.

Participating in This Clinical Trial

Inclusion Criteria

  • 7-14 years of age – Normal objective evaluation including blood pressure – For healthy controls achieved continence both day and night before the age of 5. – For children with nocturnal enuresis at least 3 wet nights per week. – For children with enuresis clinical characteristics and at least one week of home recordings of nocturnal urine production and two days of full recording of fluid intake and urine production. Exclusion Criteria:

  • Obstipation (according to ROM IV criteria) – Day incontinence or severe urgency – Insomnia or known sleep disorders such as sleep walking, heavy snoring, night terrors or abnormal circadian rhythm. – Present or former deceases in the urinary tract, liver or in the endocrinological system. – Hypertension – Treatment with medication at the time of the study – ADHD, autism or other psychiatric disorders.

Gender Eligibility: All

Minimum Age: 7 Years

Maximum Age: 14 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Aarhus
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Søren Rittig, Professor, Study Chair, Aarhus University Hospital
  • Overall Contact(s)
    • Malthe Jessen Pedersen, Med. student, +45 22457047, maltpe@rm.dk

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.